Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Fearon

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Arthritis and Rheumatism|March 9, 2011
Interleukin-27: a master regulator in inflammationUrsula Fearon
Nature Reviews. Rheumatology|December 19, 2018
Cell metabolism as a potentially targetable pathway in RATrudy McGarry, Ursula Fearon
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targetingDouglas J Veale, Ursula Fearon
Nature Reviews. Rheumatology|December 26, 2019
Next-generation analysis of synovial tissue architectureDouglas J Veale, Ursula Fearon
RMD Open|October 29, 2015
What makes psoriatic and rheumatoid arthritis so different?Douglas James Veale, Ursula Fearon
Lancet (London, England)|June 13, 2018
The pathogenesis of psoriatic arthritisDouglas J Veale, Ursula Fearon
Ebiomedicine|July 3, 2015
Key Challenges in Rheumatic and Musculoskeletal Disease Translational ResearchUrsula Fearon, Douglas J Veale
Methods in Molecular Medicine|October 24, 2007
Angiogenesis in arthritis: methodological and analytical detailsUrsula Fearon, Douglas J Veale
Annals of the Rheumatic Diseases|May 27, 2017
Response to: ustekinumab inhibits Th1 and Th17 polarisation in a giant-cell arteritis patient by Samson <i>et al</i>Richard Conway, Ursula Fearon, Eamonn S Molloy
Seminars in Immunopathology|May 17, 2017
Cellular and molecular perspectives in rheumatoid arthritisDouglas J Veale, Carl Orr, Ursula Fearon
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Arthritis and Rheumatism|March 9, 2011
Interleukin-27: a master regulator in inflammationUrsula Fearon
Nature Reviews. Rheumatology|December 19, 2018
Cell metabolism as a potentially targetable pathway in RATrudy McGarry, Ursula Fearon
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targetingDouglas J Veale, Ursula Fearon
Nature Reviews. Rheumatology|December 26, 2019
Next-generation analysis of synovial tissue architectureDouglas J Veale, Ursula Fearon
RMD Open|October 29, 2015
What makes psoriatic and rheumatoid arthritis so different?Douglas James Veale, Ursula Fearon
Lancet (London, England)|June 13, 2018
The pathogenesis of psoriatic arthritisDouglas J Veale, Ursula Fearon
Ebiomedicine|July 3, 2015
Key Challenges in Rheumatic and Musculoskeletal Disease Translational ResearchUrsula Fearon, Douglas J Veale
Methods in Molecular Medicine|October 24, 2007
Angiogenesis in arthritis: methodological and analytical detailsUrsula Fearon, Douglas J Veale
Annals of the Rheumatic Diseases|May 27, 2017
Response to: ustekinumab inhibits Th1 and Th17 polarisation in a giant-cell arteritis patient by Samson <i>et al</i>Richard Conway, Ursula Fearon, Eamonn S Molloy
Seminars in Immunopathology|May 17, 2017
Cellular and molecular perspectives in rheumatoid arthritisDouglas J Veale, Carl Orr, Ursula Fearon
Pageof 15